Dimensional Fund Advisors LP Precision Biosciences Inc Transaction History

Dimensional Fund Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.52 - $0.91 $116 - $203	-224 Reduced 0.23%	95,463 $50,000
Q3 2022 Nov 10, 2022	SELL	$1.22 - $40.8 $98,308 - $3.29 Million	-80,581 Reduced 45.72%	95,687 $125,000
Q2 2022 Aug 12, 2022	SELL	$1.15 - $3.34 $117,778 - $342,069	-102,416 Reduced 36.75%	176,268 $282,000
Q1 2022 May 13, 2022	SELL	$2.96 - $7.76 $41,238 - $108,112	-13,932 Reduced 4.76%	278,684 $858,000
Q4 2021 Feb 09, 2022	BUY	$7.4 - $11.66 $2.17 Million - $3.41 Million	292,616 New	292,616 $2.17 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $657M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.